1-9 of 9
Elena Usacheva
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is Quality of Life (QOL) Predictive for Clinical Response in Chronic Phase-Chronic Myeloid Leukemia (CP-CML) Patients Treated with Dasatinib?

Tatiana Ionova, DSc, Natalia Bulieva, MD, Anatoly Golenkov, MDProf, Taras Gritsenko, MD, Lilia Kozlova, MD Prof, Galina Kuchma, MD PhD, Elza Lomaia, MD, Elena Machulaytene, MD, Tatiana Nikitina, PhD, Natalia Novitskaya, MD PhD, Elena Usacheva, MD PhD, Tatiana Shneider, MD, Elena Trifonova, MD PhD, Olga Vinogradova, MD PhD, Anna Zinkovskaya
Journal: Blood
Blood (2017) 130 (Supplement 1): 2181.
https://doi.org/10.1182/blood.V130.Suppl_1.2181.2181
Published: 2017
Journal Articles

Quality of Life (QoL) and Clinical Outcomes of Dasatinib Treatment in TKI-Naive and Early Switched from Imatinib Patients with Chronic Myeloid Leukemia in Chronic Phase (CP CML) in a Real World Setting

Tatyana Ionova, PhD, Natalia Bulieva, MD, Olga Vinogradova, MD PhD, Kira Kurbatova, Elza Lomaia, MD PhD, Tatyana Nikitina, MD PhD, Natalia Novitskaya, Anna Rodionova, MD PhD, Elena Usacheva, Marina Chukavina, Marina Shumkova
Journal: Blood
Blood (2016) 128 (22): 5456.
https://doi.org/10.1182/blood.V128.22.5456.5456
Published: 2016
Journal Articles

Patient-Reported Outcomes in Myelofibrosis Patients Help to Identify Patients' Needs

Tatyana Ionova, PhD, Tatyana Nikitina, MD PhD, Elza Lomaia, MD PhD, Alexandr Myasnikov, MD PhD, Tatyana Pospelova, MD PhD, Andrey Evseev, MD PhD, Taras Gritsenko, MD PhD, Anna Lyamkina, MD PhD, Elena Machulaytene, MD PhD, Elena Usacheva, MD PhD, Anna Rodionova, MD PhD, Kira Kurbatova
Journal: Blood
Blood (2015) 126 (23): 5198.
https://doi.org/10.1182/blood.V126.23.5198.5198
Published: 2015
Journal Articles

Outcomes of Second-Line Treatment By Dasatinib in Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia Patients with and without Comorbidities

Tatyana Ionova, PhD, Tatyana Nikitina, MD PhD, Galina Kuchma, MD PhD, Elza Lomaia, MD PhD, Tatyana Shnaider, MD PhD, Elena Usacheva, MD PhD, Kira Kurbatova
Journal: Blood
Blood (2015) 126 (23): 5147.
https://doi.org/10.1182/blood.V126.23.5147.5147
Published: 2015
Journal Articles

Crude and Age-Adjusted Ph+/Bcr-Abl+ Chronic Myeloid Leukemia Incidence Rate in St. Petersburg and Leningrad Region Between 2006–2011

Kudrat Abdulkadyrov, Elza Lomaia, Natalia Lazorko, Vasiliy Shuvaev, Alla Abdulkadyrova, Irina Martinkevich, Elena Usacheva, Vera Udalieva, Irina Zotova, Elena Machulaitene, Natalia Ilina, Elena Karyagina, Irina Kholopova, Ekaterina Romanova, Eugenia Sbityakova, Tatiana Shneider, Andrey Zaritskey
Journal: Blood
Blood (2012) 120 (21): 4432.
https://doi.org/10.1182/blood.V120.21.4432.4432
Published: 2012
Journal Articles

Busulfan Exposure Decrease CCyR Rate On Imatinib Therapy - Impact On Recent Pretreatment

Irina Dyagil, Elza Lomaia, Kudrat Abdulkadirov, Elena Goryunova, Natalia Lazorko, Ekaterina Romanova, Eugenia Sbityakova, Alla Abdulkadirova, Irina Martinkevich, Vera Udalieva, Elena Usacheva, Irina Zotova, Vasiliy Shuvaev, Elena Machulaitene, Ekaterina Poznyak, Maria Ivanova, Natalia Ilina, Elena Koryagina, Tatiana Shneider, Svetlana Stepanova, Irina Dmitrenko, Natalia Babkina, Tatiana Perekhrestenko, Zvenyslava Masliak, Andrey Zaritskey
Journal: Blood
Blood (2011) 118 (21): 4452.
https://doi.org/10.1182/blood.V118.21.4452.4452
Published: 2011
Journal Articles

Only Time Before the Beginning of Treatment and Time to Achieve CCyR Influence the Stability of CCyR In CML-CP Patients On Imatinib Therapy.

Kudrat Abdulkadyrov, Elza Lomaia, Alla Abdulkadyrova, Vera Udalieva, Dgariyat Shikhbabaeva, Elena Usacheva, Irina Zotova, Elena Machulaitene, Maria Ivanova, Ekaterina Poznyak, Elena Koryagina, Natalia Ilina, Tatiana Shneider, Svetlana Stepanova, Ekaterina Romanova, Evgenia Salamatova, Natalia Lazorko, Irina Martynkevich, Vasiliy Shuvaev, Andrey Zaritskey
Journal: Blood
Blood (2010) 116 (21): 4476.
https://doi.org/10.1182/blood.V116.21.4476.4476
Published: 2010
Journal Articles

6 Year Experience of Treatment by Imatinib in CML CP Patientsin 6 Million Population Region of Russia(Saint-Petersburg and Leningrad region)with Impact On Time and Kind of Pretreatment.

Kudrat Abdulkadirov, Elza Lomaia, Vasiliy Shuvaev, Alla Abdulkadirova, Vera Udalieva, Elena Usacheva, Elena Machulaitene, Irina Zotova, Ekaterina Poznyak, Elena Koryagina, Natalia Ilina, Tatiana Shneider, Svetlana Stepanova, Ekaterina Romanova, Eugenia Salamatova, Elena Goryunova, Natalija Lazorko, Irina Martinkevich, Andrey Zaritskey
Journal: Blood
Blood (2009) 114 (22): 4278.
https://doi.org/10.1182/blood.V114.22.4278.4278
Published: 2009
Journal Articles

Experience in Second Line TKI Treatment in 6 Million Region of Russia (St-Petersburg and Leningrad region).

Kudrat Abdulkadirov, Elza Lomaia, Alla Abdulkadirova, Vasiliy Shuvaev, Vera Udalieva, Elena Usacheva, Elena Machulaitene, Irina Zotova, Ekaterina Poznyak, Elena Koryagina, Natalia Ilina, Tatiana Shneider, Svetlana Stepanova, Ekaterina Romanova, Eugenia Salamatova, Elena Goryunova, Natalija Lazorko, Irina Martinkevich, Andrey Zaritskey
Journal: Blood
Blood (2009) 114 (22): 4288.
https://doi.org/10.1182/blood.V114.22.4288.4288
Published: 2009